Nonopioid pharmacological management of acute low back pain: A level I of evidence systematic review

Acute low back pain (LBP) imposes a significant socioeconomical burden as it is the condition that, worldwide, cause the most disability. Nonetheless, the literature regarding the best pharmacological management of acute LBP is limited, and the indications available in the literature are conflicting. This work investigates whether the pharmacological management of acute LBP can effectively reduce pain and disability, and aims to identify which drugs show the highest efficacy. This systematic review was conducted according to the 2020 PRISMA statement. In September 2022, PubMed, Scopus, and Web of Science were accessed. All the randomized controlled trials investigating the efficacy of myorelaxants, nonsteroidal anti‐inflammatory drugs (NSAIDs), and paracetamol for acute LPB were accessed. Only studies that investigated the lumbar spine were included. Only studies reporting on patients with acute LBP with symptom duration of less than 12 weeks were included. Only patients older than 18 years and with nonspecific low back pain were included. Studies that investigated the use of opioids in acute LBP were not considered. Data from 18 studies and 3478 patients were available. Myorelaxants and NSAIDs were effective in reducing pain and disability in acute LBP at approximately one week. The combination of NSAIDs and paracetamol was associated with a greater improvement than the use of NSAIDs alone, but paracetamol alone did not induce any significant improvement. Placebo was not effective in reducing pain. Clinical Significance: Myorelaxants, NSAIDs, and NSAIDs with paracetamol could reduce pain and disability in patients with acute LBP.

[1]  A. Chiarotto,et al.  Individual patient education for managing acute and/or subacute low back pain: little additional benefit for pain and function compared to placebo. A systematic review with meta-analysis of randomised controlled trials. , 2022, The Journal of orthopaedic and sports physical therapy.

[2]  Adrian Roesner,et al.  Edukation bei akuten lumbalen Rückenschmerzen , 2022, Der Schmerz.

[3]  A. Schäfer,et al.  [Patient education for acute low back pain : Contents of pain education in patients with acute non-specific low back pain - a scoping review]. , 2022, Schmerz.

[4]  Mark I. Johnson,et al.  Efficacy and safety of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain in adults: a systematic review and meta-analysis of 381 studies (the meta-TENS study) , 2022, BMJ Open.

[5]  Muath A Shraim,et al.  The association between early MRI and length of disability in acute lower back pain: a systematic review and narrative synthesis , 2021, BMC Musculoskeletal Disorders.

[6]  Boyu Wu,et al.  Efficacy and safety of acupuncture in treating acute low back pain: a systematic review and bayesian network meta-analysis. , 2021, Annals of palliative medicine.

[7]  A. Turolla,et al.  Effectiveness of treatments for acute and subacute mechanical non-specific low back pain: a systematic review with network meta-analysis , 2021, British Journal of Sports Medicine.

[8]  A. Starkweather,et al.  Investigating key predictors of persistent low back pain: A focus on psychological stress. , 2021, Applied nursing research : ANR.

[9]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, Systematic Reviews.

[10]  T. Akgül,et al.  The effect of oral magnesium supplementation on acute non-specific low back pain: Prospective randomized clinical trial. , 2021, The American journal of emergency medicine.

[11]  D. Jérez-Mayorga,et al.  Isokinetic Trunk Strength in Acute Low Back Pain Patients Compared to Healthy Subjects: A Systematic Review , 2021, International journal of environmental research and public health.

[12]  J. Price.  A mixed treatment comparison of selected osteopathic techniques used to treat acute nonspecific low back pain: a proof of concept and plan for further research , 2021, Journal of osteopathic medicine.

[13]  Azrah Y. Ahmed,et al.  Treatments for Acute Pain: A Systematic Review , 2020 .

[14]  D. A. van der Windt,et al.  Evidence‐based treatment recommendations for neck and low back pain across Europe: A systematic review of guidelines , 2020, European journal of pain.

[15]  J. Eschweiler,et al.  The pharmacological management of chronic lower back pain , 2020, Expert opinion on pharmacotherapy.

[16]  M. DePalma,et al.  Red flags of low back pain. , 2020, JAAPA : official journal of the American Academy of Physician Assistants.

[17]  C. Cook,et al.  Harms and benefits of opioids for management of non-surgical acute and chronic low back pain: a systematic review , 2020, British Journal of Sports Medicine.

[18]  Likang Xu,et al.  Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017 , 2020, JAMA network open.

[19]  B. Koes,et al.  Non-steroidal anti-inflammatory drugs for acute low back pain. , 2020, The Cochrane database of systematic reviews.

[20]  R. Elnemr,et al.  The Visual Analogue Scale Versus Numerical Rating Scale in Measuring Pain Severity and Predicting Disability in Low Back Pain , 2020, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[21]  E. Gallagher,et al.  Ibuprofen + acetaminophen versus ibuprofen alone for acute low back pain. An ED-based randomized study. , 2019, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[22]  Allen L. Ho,et al.  Patterns of Opioid and Benzodiazepine Use in Opioid-Naïve Patients with Newly Diagnosed Low Back and Lower Extremity Pain , 2019, Journal of General Internal Medicine.

[23]  A. Goode,et al.  The Effect of Timing of Physical Therapy for Acute Low Back Pain on Health Services Utilization: A Systematic Review. , 2019, Archives of physical medicine and rehabilitation.

[24]  M. Jinga,et al.  Effect of a New Synergistic Combination of Low Doses of Acetylsalicylic Acid, Caffeine, Acetaminophen, and Chlorpheniramine in Acute Low Back Pain , 2019, Front. Pharmacol..

[25]  E. Gallagher,et al.  A Randomized, Placebo-Controlled Trial of Ibuprofen Plus Metaxalone, Tizanidine, or Baclofen for Acute Low Back Pain. , 2019, Annals of emergency medicine.

[26]  L. Thabane,et al.  Adverse Outcomes Associated with Prescription Opioids for Acute Low Back Pain: A Systematic Review and Meta-Analysis. , 2019, Pain physician.

[27]  R. Uppin,et al.  Efficacy and Safety of Combination of NSAIDs and Muscle Relaxants in the Management of Acute Low Back Pain , 2019, Pain and Therapy.

[28]  B. Koes,et al.  Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview , 2018, European Spine Journal.

[29]  Jianzhong Su,et al.  Transitioning from Acute to Chronic Pain: An Examination of Different Trajectories of Low-Back Pain , 2018, Healthcare.

[30]  M. Sekiguchi,et al.  Randomized open-label [corrected] non-inferiority trial of acetaminophen or loxoprofen for patients with acute low back pain. , 2018, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[31]  M. Davitt,et al.  A Randomized, Double‐Blind, Placebo‐Controlled Trial of Naproxen With or Without Orphenadrine or Methocarbamol for Acute Low Back Pain , 2017, Annals of emergency medicine.

[32]  B. Koes,et al.  Advice for acute low back pain: a comparison of what research supports and what guidelines recommend. , 2017, The spine journal : official journal of the North American Spine Society.

[33]  B. Friedman,et al.  Diazepam Is No Better Than Placebo When Added to Naproxen for Acute Low Back Pain , 2017, Annals of emergency medicine.

[34]  Timothy J Wilt,et al.  Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. , 2017, Annals of internal medicine.

[35]  M. Scheinberg,et al.  Double-blind, randomized, double-dummy clinical trial comparing the efficacy of ketorolac trometamol and naproxen for acute low back pain , 2016, Drug design, development and therapy.

[36]  B. Koes,et al.  Back schools for acute and subacute non-specific low-back pain. , 2016, The Cochrane database of systematic reviews.

[37]  D. Wallis,et al.  Clinical Efficacy of Celecoxib Compared to Acetaminophen in Chronic Nonspecific Low Back Pain: Results of a Randomized Controlled Trial , 2015, Arthritis care & research.

[38]  G. Moseley,et al.  Effect of Primary Care-Based Education on Reassurance in Patients With Acute Low Back Pain: Systematic Review and Meta-analysis. , 2015, JAMA internal medicine.

[39]  W. Krijnen,et al.  Expectations about recovery from acute non-specific low back pain predict absence from usual work due to chronic low back pain: a systematic review. , 2012, Journal of physiotherapy.

[40]  L. Costa,et al.  The prognosis of acute and persistent low-back pain: a meta-analysis , 2012, Canadian Medical Association Journal.

[41]  J. Cook,et al.  Results of a randomized controlled trial of mental illness self-management using Wellness Recovery Action Planning. , 2012, Schizophrenia bulletin.

[42]  P. Kotwal,et al.  Clinical Comparative Study: Efficacy and Tolerability of Tolperisone and Thiocolchicoside in Acute Low Back Pain and Spinal Muscle Spasticity , 2012, Asian spine journal.

[43]  F. Blyth,et al.  The Epidemiology of low back pain. , 2010, Best practice & research. Clinical rheumatology.

[44]  P. Randelli,et al.  Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study. , 2008, European review for medical and pharmacological sciences.

[45]  R. Deyo,et al.  Back Pain Prevalence and Visit Rates: Estimates From U.S. National Surveys, 2002 , 2006, Spine.

[46]  H. Ursin,et al.  Chapter 4 European guidelines for the management of chronic nonspecific low back pain , 2006, European Spine Journal.

[47]  S. Karamursel,et al.  Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain , 2005, International journal of clinical practice.

[48]  R. Mcnutt,et al.  Acute Severe Low Back Pain: A Population-based Study of Prevalence and Care-seeking , 1996, Spine.

[49]  Martha Harwit.  To Oxford , 1992, Annals of Internal Medicine.

[50]  M. Lazovic,et al.  Ibuprofen plus paracetamol versus ibuprofen in acute low back pain: a randomized open label multicenter clinical study. , 2017, Acta reumatologica portuguesa.

[51]  Kylie A. Williams,et al.  Interventions available over the counter and advice for acute low back pain: systematic review and meta-analysis. , 2014, The journal of pain : official journal of the American Pain Society.

[52]  Serge Poiraudeau,et al.  Back pain , 2010, La Revue du praticien.

[53]  R. Viladot,et al.  Effects of Two Different Doses of Eperisone in the Treatment of Acute Low Back Pain , 2009 .

[54]  H. Sacks,et al.  Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm. , 2008, Current medical research and opinion.

[55]  H. Zippel,et al.  A Multicentre, Randomised, Double- Blind Study Comparing the Efficacy and Tolerability of Intramuscular Dexketoprofen versus Diclofenac in the Symptomatic Treatment of Acute Low Back Pain , 2007, Clinical drug investigation.

[56]  B. Koes,et al.  Low back pain (acute). , 2006, Clinical evidence.

[57]  E. Ginter,et al.  Effect of ascorbic acid on plasma cholesterol in humans in a long-term experiment. , 1977, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.